{"id":2033,"date":"2022-07-31T15:23:44","date_gmt":"2022-07-31T15:23:44","guid":{"rendered":"https:\/\/mgpindia.com\/fend\/?page_id=2033"},"modified":"2024-10-04T13:36:14","modified_gmt":"2024-10-04T13:36:14","slug":"adult","status":"publish","type":"page","link":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/adult\/","title":{"rendered":"Adult"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Header” _builder_version=”4.17.4″ _module_preset=”default” background_color=”#F5F0EB” custom_padding=”0px|0px|0px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”100px||||false|false” custom_padding_tablet=”30px||||false|false” custom_padding_phone=”20px||||false|false” custom_padding_last_edited=”on|desktop” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” header_font=”Roboto|500|||||||” header_text_color=”#000000″ header_font_size=”70px” header_line_height=”1.15em” custom_padding=”|80px|||false|false” custom_padding_tablet=”|80px|||false|false” custom_padding_phone=”|80px|||false|false” custom_padding_last_edited=”on|phone” header_font_size_tablet=”40px” header_font_size_phone=”24px” header_font_size_last_edited=”on|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n

Adult Protocol<\/h1>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/xray-cropped.jpg” _builder_version=”4.17.6″ _module_preset=”default” custom_margin=”|-10vw|||false|false” custom_margin_tablet=”|0%|||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row custom_padding_last_edited=”on|phone” _builder_version=”4.27.2″ _module_preset=”default” background_color=”#FFFFFF” background_image=”https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/02\/high-school_34.png” background_size=”initial” background_position=”top_left” background_repeat=”repeat-x” z_index=”500″ custom_margin=”||||false|false” custom_margin_tablet=”0px||||false|false” custom_margin_last_edited=”off|desktop” custom_padding=”40px|40px|40px|40px|true|true” custom_padding_tablet=”30px|30px|30px|30px|true|true” custom_padding_phone=”20px|20px|20px|20px|true|true” box_shadow_style=”preset3″ box_shadow_vertical=”60px” box_shadow_blur=”60px” box_shadow_spread=”0px” box_shadow_color=”rgba(14,15,43,0.1)” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” custom_padding=”40px||40px||true|false” custom_padding_tablet=”40px||40px||true|false” custom_padding_phone=”40px||40px||true|false” custom_padding_last_edited=”on|desktop” header_font_size_tablet=”55px” header_font_size_last_edited=”off|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n

Improved tuberculosis diagnostic tests are a key component of strategies to reduce the global tuberculosis burden and morbidity. Of highest priority are tests that can be performed on readily available clinical specimens other than sputum, that can be used for triage purposes and at point-of-care, and that can predict the future development of active tuberculosis. Advances in biology and technology have facilitated the development of novel in vitro assays; however, rigorous evaluations using specimens from individuals in intended settings of use are needed to identify and prioritize the best-performing tests and inform their iterative development.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”adult” _builder_version=”4.17.6″ _module_preset=”default” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.6″ text_font=”|600|||||||” text_text_color=”#ffffff” text_line_height=”1.8em” header_text_color=”#000000″ header_2_font=”Roboto||||||||” header_2_text_align=”center” header_2_text_color=”#000000″ header_2_font_size=”40px” header_2_line_height=”1.7em” background_color=”#2E548A” text_orientation=”center” max_width=”600px” custom_padding=”100px||100px||true|true” link_option_url=”#adult” header_2_font_size_tablet=”48px” header_2_font_size_phone=”30px” header_2_font_size_last_edited=”on|phone” border_radii=”on|50px|50px|50px|50px” border_color_all=”#BE7B61″ box_shadow_style=”preset3″ global_colors_info=”{}” background__hover_enabled=”on|hover” background_color__hover=”rgba(214,214,214,0.7)” background_enable_color__hover=”on”]<\/p>\n

\"\"<\/p>\n

[\/et_pb_text][et_pb_team_member name=”Susan Dorman” position=”MD” image_url=”https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/06\/Susan-Dorman.jpg” facebook_url=”mailto:dorman@musc.edu” _builder_version=”4.17.6″ _module_preset=”default” header_font_size=”16px” body_font_size=”13px” body_line_height=”1.5em” module_alignment=”center” link_option_url=”https:\/\/fend-tb.org\/susan-dorman\/” box_shadow_style_image=”preset3″ global_colors_info=”{}”][\/et_pb_team_member][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” header_font_size_tablet=”55px” header_font_size_last_edited=”off|desktop” locked=”off” global_colors_info=”{}”]<\/p>\n

The Adult FEND for TB program enrolls adults in whom evaluation for tuberculosis is warranted based on signs and symptoms, noninvasively obtaining relevant clinical specimens, and meticulously testing those specimens using conventional WHO-endorsed tuberculosis diagnostics to classify each participant with regard to tuberculosis status. This protocol also comprises investigational in vitro diagnostic assays that will be evaluated in the laboratories over the life of the program and the statistical approaches for identifying the best performing assays.<\/p>\n

The following protocol design features enhance the efficiency with which investigational tuberculosis diagnostic assays are formally evaluated to enable the rapid identification of the most promising assays and speeding their movement through the pipeline to tuberculosis patients and programs:<\/p>\n